AliveCor, Inc., a pioneering force in the digital health industry, is headquartered in the United States. Founded in 2010, the company has established itself as a leader in mobile ECG technology, focusing on empowering individuals to take control of their heart health. With a strong presence across North America and Europe, AliveCor's flagship product, KardiaMobile, offers users the ability to monitor their heart rhythm conveniently and accurately. This innovative device stands out for its clinical-grade ECG capabilities, enabling timely detection of atrial fibrillation and other cardiac conditions. Recognised for its contributions to telehealth, AliveCor has achieved significant milestones, including FDA clearances and partnerships with major healthcare providers. As a result, the company continues to enhance its market position, driving advancements in personal health monitoring and transforming the way patients engage with their cardiovascular health.
How does AliveCor, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AliveCor, Inc.'s score of 88 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AliveCor, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of GE HealthCare Technologies Inc., which may influence its climate commitments and reporting practices. While AliveCor has not set its own reduction targets or climate pledges, it is important to note that any potential climate initiatives or targets may be inherited from its parent company, GE HealthCare Technologies Inc. This includes any commitments made under the Science Based Targets initiative (SBTi) and other climate-related frameworks. However, specific details regarding these initiatives or targets have not been disclosed. As a subsidiary, AliveCor's climate strategy may align with the broader sustainability goals of GE HealthCare Technologies Inc., which could include efforts to reduce emissions across various scopes. Nonetheless, without specific data or commitments from AliveCor itself, the company's individual climate impact remains unclear.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 137,254,000 | 000,000,000 | 000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 |
| Scope 2 | 192,207,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000,000 |
AliveCor, Inc.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with detailed category breakdown helping identify key emission sources across their value chain.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AliveCor, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.